U.S. flag

An official website of the United States government

NM_170707.4(LMNA):c.356+1G>A AND Charcot-Marie-Tooth disease type 2

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Oct 19, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000689313.8

Allele description [Variation Report for NM_170707.4(LMNA):c.356+1G>A]

NM_170707.4(LMNA):c.356+1G>A

Gene:
LMNA:lamin A/C [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q22
Genomic location:
Preferred name:
NM_170707.4(LMNA):c.356+1G>A
HGVS:
  • NC_000001.11:g.156115275G>A
  • NG_008692.2:g.37703G>A
  • NM_001282625.2:c.356+1G>A
  • NM_001282626.2:c.356+1G>A
  • NM_001406983.1:c.356+1G>A
  • NM_001406984.1:c.356+1G>A
  • NM_001406985.1:c.356+1G>A
  • NM_001406986.1:c.-68+1G>A
  • NM_001406990.1:c.-46+1G>A
  • NM_001406991.1:c.356+1G>A
  • NM_001406992.1:c.356+1G>A
  • NM_001406993.1:c.-203+8452G>A
  • NM_001406994.1:c.-309+1G>A
  • NM_001406995.1:c.-46+1G>A
  • NM_001406999.1:c.-489+1G>A
  • NM_001407000.1:c.-309+1G>A
  • NM_001407001.1:c.-152+1G>A
  • NM_001407002.1:c.-46+1G>A
  • NM_001407003.1:c.-203+8452G>A
  • NM_005572.4:c.356+1G>A
  • NM_170707.4:c.356+1G>AMANE SELECT
  • NM_170708.4:c.356+1G>A
  • LRG_254t2:c.356+1G>A
  • LRG_254:g.37703G>A
  • NC_000001.10:g.156085066G>A
  • NM_170707.2:c.356+1G>A
  • NM_170707.3:c.356+1G>A
Links:
dbSNP: rs794728589
NCBI 1000 Genomes Browser:
rs794728589
Molecular consequence:
  • NM_001406993.1:c.-203+8452G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407003.1:c.-203+8452G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001282625.2:c.356+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001282626.2:c.356+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001406983.1:c.356+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001406984.1:c.356+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001406985.1:c.356+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001406986.1:c.-68+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001406990.1:c.-46+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001406991.1:c.356+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001406992.1:c.356+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001406994.1:c.-309+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001406995.1:c.-46+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001406999.1:c.-489+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001407000.1:c.-309+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001407001.1:c.-152+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001407002.1:c.-46+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_005572.4:c.356+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_170707.4:c.356+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_170708.4:c.356+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Name:
Charcot-Marie-Tooth disease type 2
Synonyms:
Charcot-Marie-Tooth, Type 2
Identifiers:
MONDO: MONDO:0018993; MedGen: C0270914

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000816956Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Oct 19, 2020)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Quantitative expression of the mutated lamin A/C gene in patients with cardiolaminopathy.

Narula N, Favalli V, Tarantino P, Grasso M, Pilotto A, Bellazzi R, Serio A, Gambarin FI, Charron P, Meder B, Pinto Y, Elliott PM, Mogensen J, Bolognesi M, Bollati M, Arbustini E.

J Am Coll Cardiol. 2012 Nov 6;60(19):1916-20. doi: 10.1016/j.jacc.2012.05.059. Epub 2012 Oct 10.

PubMed [citation]
PMID:
23062543

Splicing in action: assessing disease causing sequence changes.

Baralle D, Baralle M.

J Med Genet. 2005 Oct;42(10):737-48. Review.

PubMed [citation]
PMID:
16199547
PMCID:
PMC1735933
See all PubMed Citations (5)

Details of each submission

From Invitae, SCV000816956.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

Disruption of this splice site has been observed in individuals with clinical features of LMNA-related conditions (PMID: 23062543, Invitae). ClinVar contains an entry for this variant (Variation ID: 200933). For these reasons, this variant has been classified as Pathogenic. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in LMNA are known to be pathogenic (PMID: 18585512, 18926329). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. This variant is not present in population databases (ExAC no frequency). This sequence change affects a donor splice site in intron 1 of the LMNA gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024